Clinical Operations and Medical Affairs

The Clinical Operations and Medical Affairs team at Calliditas Therapeutics is responsible for overseeing and executing clinical trials, particularly the global Phase 3 study for Nefecon in IgA nephropathy. They ensure compliance with regulatory standards, manage medical communications, and provide strategic support throughout the drug development process. The team collaborates cross-functionally to enhance patient outcomes and facilitate the successful commercialization of innovative therapies for unmet medical needs.